3Followers on Owler

Etubics

Read more
Frank R. Jones's photo - Chairman & CEO of Etubics

Chairman & CEO

Frank R. Jones

CEO Approval Rating

88/100

Founded

2003

Headquarters

Status

PrivateSubsidiary of immunitybio

Social Links

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
1-25
Agree?
Funding
$21.4M

Etubics Competitors and Alternatives

1
3
5
7
9
2
4
6
8
10

Etubics News

Etubics Press Releases

Etubics Videos

Etubics Headquarters

410 West Harrison Street Suite 200

Seattle, Washington98119-4007

1-206-838-5110

Driving Directions »

Etubics Summary

ABOUT

Overview

Etubics is a biopharmaceutical company that specializes in developing targeted immunotherapies and vaccine products. Etubics was founded in 2003. Etubics' headquarters is located in Seattle, Washington, USA 98119-4007. Etubics' Chairman & CEO, Frank ...

CEO

Etubics's Chairman & CEO, Frank R. Jones, currently has an approval rating of 88%. Etubics's primary competitors are OyaGen, GeoVax & Immunize Rx.

Acquisitions

There have been no acquisitions found related to Etubics

Investments

Recent investment data cannot be found related to Etubics

Frequently Asked Questions about Etubics

  1. When was Etubics founded?

    Etubics was founded in 2003
  2. Who is Etubics's CEO?

    Etubics's CEO is Frank R. Jones
  3. How much revenue does Etubics generate?

    Etubics generates $7M in revenue
  4. How much funding does Etubics have?

    Etubics has historically raised $21.4M in funding
  1. Where is Etubics's headquarters?

    Etubics's headquarters is in Seattle Washington, USA
  2. How many employees does Etubics have?

    Etubics has 15 employees
  3. What sector does Etubics operate in?

    Etubics is in Pharmaceuticals, Biotechnology
  4. Who are Etubics's competitors?

    Etubics's top competitors are OyaGen, GeoVax, Immunize Rx

Trending Companies